BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cheng X, Cao Y, Wang X, Cheng L, Liu Y, Lei J, Peng W, Shi D. Systematic Pan-Cancer Analysis of KLRB1 with Prognostic Value and Immunological Activity across Human Tumors. J Immunol Res 2022;2022:5254911. [PMID: 35028320 DOI: 10.1155/2022/5254911] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Yuan J, Wang Y, Wang X, Zhang W, Ding R, Yue S, Li X. Construction and experimental verification of user-friendly molecular subtypes mediated by immune-associated genes in hepatocellular carcinoma. Front Oncol 2022;12:924059. [DOI: 10.3389/fonc.2022.924059] [Reference Citation Analysis]
2 Ognibene M, De Marco P, Parodi S, Meli M, Di Cataldo A, Zara F, Pezzolo A. Genomic Analysis Made It Possible to Identify Gene-Driver Alterations Covering the Time Window between Diagnosis of Neuroblastoma 4S and the Progression to Stage 4. Int J Mol Sci 2022;23:6513. [PMID: 35742955 DOI: 10.3390/ijms23126513] [Reference Citation Analysis]
3 Rosalia B, Matteo B, Ester B, Giovanni Z, Daniela Claudia M, Pier Giulio C, Giuseppe E, Angela I. Tissue-Resident Innate Immune Cell-Based Therapy: A Cornerstone of Immunotherapy Strategies for Cancer Treatment. Front Cell Dev Biol 2022;10:907572. [DOI: 10.3389/fcell.2022.907572] [Reference Citation Analysis]